How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
Show:
| PsychonautWiki | TripSit | Pharmacology | ||
|---|---|---|---|---|
| Classification | ||||
| Class / category | — | ≈ | ||
| Also known as | Piracetam | nootropillucetamnoostanbreinoxoikamidgeratambiotropil | — | ≠ |
| Safety | ||||
| Addiction potential | not addictive with a low potential for abuse | — | — | |
| Dose · Oral | ||||
| Threshold | 0.25 g | — | — | |
| Light | 0.5–2 g | — | — | |
| Common | 2–3 g | 1200–4800 mg | — | ≠ |
| Strong | 3–5 g | — | — | |
| Heavy | 5 g+ | — | — | |
| Duration | ||||
| Onset | 30–90 minutes | 15–35 minutes | — | ≠ |
| Total | 4–8 hours | 3–6 hours | — | ≠ |
| After-effects | — | 1–6 hours | — | |
| Pharmacology | ||||
| Receptor activity | — | — | GluA1GluA2GluA3GluA4 | |
| Half-life | — | — | The plasma half life of piracetam is approximately 5 hours following oral or intravenous administration. The half life in the cerebrospinal fluid was 8.5 hours. ... The plasma half-life is 5.0 hours, in young adult men. | |
| Protein binding | — | — | Piracetam is not reported to be bound to plasma proteins. | |
Dose at a glance
Each database's primary-route ladder on one shared scale — see where ranges line up or shift.
PsychonautWiki oral
TripSit Oral
04800 g
LightCommonStrongHeavy
Duration at a glance
Total duration on one shared scale.
PsychonautWiki
TripSit
TripSit summary
A racetam nootropic claimed by many to have cognitive benefits however this has never been strongly supported in healthy individuals. Prescribed in the UK as a treatment for myoclonus. Potentially an ampakine. One of the first popular 'nootropics.'
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.